drugset / Trial / NCT02924090

Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression

NCT02924090

Phase 4 Unknown 48 enrolled University of Manitoba
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized controlled study assessing the effect of pre-emptive hyperventilation on ECT seizure duration, cerebral desaturation and remission of depressive symptoms in patients with Major Depressive Disorder. Comparison of etomidate and ketamine on remission of depressive symptoms with and without pre-emptive hyperventilation will also be studied.

Timeline

Start
2016-09
Primary completion
2017-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etomidate Small molecule 0.3 mg/kg Intravenous
Comparator Ketamine Small molecule 0.5 mg/kg Intravenous
Comparator Ketamine Small molecule 1 mg/kg Intravenous

Indications